The use of compounds that modulate Clk as agents to prevent diet‐induced obesity (DIO) was as shown earlier where treatment of mice with TG003 was shown to decrease lipid accumulation and result in weight loss with 30–100 mg/kg IP.52 This evidence concerns the gene CLK1 and obesity disorder.